Matthew Ferguson - 08 Mar 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Jeffrey Hamet, Attorney-in-Fact for Matthew Ferguson
Issuer symbol: ELUT
Transactions as of: 08 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2023, 20:11:04 UTC
Previous filing: 05 Dec 2022
Next filing: 21 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AZYO	Class A Common Stock	Options Exercise	$0	+1,287	+2.8%	$0.000000	46,504	08 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AZYO	Restricted Stock Units	Options Exercise	$0	-1,287	-33%	$0.000000	2,575	08 Mar 2023	Class A Common Stock	1,287		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2	On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.